{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T23:21:19Z","timestamp":1790032879266,"version":"4.0.1"},"update-to":[{"DOI":"10.1371\/journal.pntd.0007132","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,3,5]],"date-time":"2019-03-05T00:00:00Z","timestamp":1551744000000}}],"reference-count":31,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2019,2,21]],"date-time":"2019-02-21T00:00:00Z","timestamp":1550707200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0007132","type":"journal-article","created":{"date-parts":[[2019,2,21]],"date-time":"2019-02-21T18:50:40Z","timestamp":1550775040000},"page":"e0007132","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":34,"title":["Long term outcomes and prognostics of visceral leishmaniasis in HIV infected patients with use of pentamidine as secondary prophylaxis based on CD4 level: a prospective cohort study in Ethiopia"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3595-6323","authenticated-orcid":true,"given":"Ermias","family":"Diro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6110-014X","authenticated-orcid":true,"given":"Tansy","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koert","family":"Ritmeijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helina","family":"Fikre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Abongomera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aderajew","family":"Kibret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9lia","family":"Bardonneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1689-8770","authenticated-orcid":true,"given":"Peninah","family":"Soipei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Mutinda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Omollo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"van Griensven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard E.","family":"Zijlstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique","family":"Wasunna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Alvar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asrat","family":"Hailu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neal","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9verine","family":"Blesson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,2,21]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1128\/CMR.00061-07","article-title":"The relationship between leishmaniasis and AIDS: the second 10 years","volume":"21","author":"J Alvar","year":"2008","journal-title":"Clin Microbiol Rev"},{"key":"ref2","first-page":"e2875","article-title":"High parasitological failure rate of visceral leishmaniasis to sodium stibogluconate among HIV co-infected adults in Ethiopia. PLoS Negl Trop Dis","volume":"8","author":"E Diro","year":"2014"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"e152","DOI":"10.1093\/cid\/cir674","article-title":"Limited effectiveness of high-dose liposomal amphotericin B (AmBisome) for treatment of visceral leishmaniasis in an Ethiopian population with high HIV prevalence","volume":"53","author":"K Ritmeijer","year":"2011","journal-title":"Clin Infect Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/B978-0-12-407679-2.00005-3","article-title":"Mechanisms of immune evasion in leishmaniasis","volume":"82","author":"G Gupta","year":"2013","journal-title":"Adv Appl Microbiol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0163-4453(03)00002-1","article-title":"Visceral leishmaniasis. Persistence of parasites in lymph nodes after clinical cure","volume":"47","author":"J Dereure","year":"2003","journal-title":"J Infect"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1080\/00365540151061049","article-title":"Visceral leishmaniasis in an AIDS patient on successful antiretroviral therapy: failure of parasite eradication despite increase in CD4+ T-cell count but low CD8+ T-cell count","volume":"33","author":"A Petter","year":"2001","journal-title":"Scand J Infect Dis"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/j.1468-1293.2010.00846.x","article-title":"'Active chronic visceral leishmaniasis' in HIV-1-infected patients demonstrated by biological and clinical long-term follow-up of 10 patients","volume":"11","author":"N Bourgeois","year":"2010","journal-title":"HIV Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1046\/j.1365-3156.2002.00893.x","article-title":"Review: HIV infection and tropical parasitic diseases\u2013deleterious interactions in both directions?","volume":"7","author":"Gundel Harms","year":"2013","journal-title":"Trop Med Int Health"},{"key":"ref9","unstructured":"CDC (2014) Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents. Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. T-15-T-25."},{"key":"ref10","unstructured":"World Health Organization (2007) Report of the Fifth Consultative Meeting on Leishmania\/HIV Coinfection, March 20\u201322, Addis Ababa, Ethiopia."},{"key":"ref11","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/jac\/dkh084","article-title":"Amphotericin B lipid complex versus no treatment in the secondary prophylaxis of visceral leishmaniasis in HIV-infected patients","volume":"53","author":"R Lopez-Velez","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00002030-199602000-00023","article-title":"Pentamidine isethionate as secondary prophylaxis against visceral leishmaniasis in HIV-positive patients","volume":"10","author":"JA Perez-Molina","year":"1996","journal-title":"AIDS"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"167","DOI":"10.4103\/0974-777X.62887","article-title":"Drug resistance in leishmaniasis","volume":"2","author":"J Chakravarty","year":"2010","journal-title":"J Glob Infect Dis"},{"key":"ref14","first-page":"e1153","article-title":"Predictors of visceral leishmaniasis relapse in HIV-infected patients: a systematic review. PLoS Negl Trop Dis","volume":"5","author":"GF Cota","year":"2011"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1086\/587899","article-title":"Concordant HIV infection and visceral leishmaniasis in Ethiopia: the influence of antiretroviral treatment and other factors on outcome","volume":"46","author":"R ter Horst","year":"2008","journal-title":"Clin Infect Dis"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"e0004087","DOI":"10.1371\/journal.pntd.0004087","article-title":"Use of Pentamidine As Secondary Prophylaxis to Prevent Visceral Leishmaniasis Relapse in HIV Infected Patients, the First Twelve Months of a Prospective Cohort Study","volume":"9","author":"E Diro","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"ref17","unstructured":"U.S.Department of Health and Human Services, National Institute of Health, and National Cancer Institute (28-5-2009) Common terminology criteria for adverse events (CTCAE)."},{"key":"ref18","doi-asserted-by":"crossref","first-page":"5080","DOI":"10.1128\/JCM.41.11.5080-5084.2003","article-title":"Real-time PCR assay for clinical management of human immunodeficiency virus-infected patients with visceral leishmaniasis","volume":"41","author":"S Bossolasco","year":"2003","journal-title":"J Clin Microbiol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1007\/BF01700556","article-title":"Visceral leishmaniasis in patients infected with the human immunodeficiency virus","volume":"16","author":"F Laguna","year":"1997","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/00005792-200101000-00006","article-title":"Visceral leishmaniasis in human immunodeficiency virus (HIV)-infected and non-HIV-infected patients. A comparative study","volume":"80","author":"V Pintado","year":"2001","journal-title":"Medicine (Baltimore)"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S0002-9343(97)89503-4","article-title":"Prophylaxis of visceral leishmaniasis in human immunodeficiency virus-infected patients","volume":"100","author":"E Ribera","year":"1996","journal-title":"Am J Med"},{"key":"ref22","unstructured":"Word Health Organization (2013) Consolidated Guidelines on Use of Antiretroviral Drugs for Treating and Preventing HIV Infection Recommendations for a Public Health Approach, World Health Organization 2013."},{"key":"ref23","unstructured":"World Health Organization (2017) Guidlines for managing advanced HIV disease and rapid initiation of antiretroviral therapy."},{"key":"ref24","doi-asserted-by":"crossref","first-page":"e0006375","DOI":"10.1371\/journal.pntd.0006375","article-title":"New insights into leishmaniasis in the immunosuppressed","volume":"12","author":"H Akuffo","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"e225","DOI":"10.1371\/journal.pntd.0000225","article-title":"Pentamidine dosage: a base\/salt confusion","volume":"2","author":"TP Dorlo","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"e3011","DOI":"10.1371\/journal.pntd.0003011","article-title":"A screen-and-treat strategy targeting visceral leishmaniasis in HIV-infected individuals in endemic East African countries: the way forward?","volume":"8","author":"J van Griensven","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1093\/cid\/cix807","article-title":"Long-term Clinical Outcomes in Visceral Leishmaniasis\/Human Immunodeficiency Virus-Coinfected Patients During and After Pentamidine Secondary Prophylaxis in Ethiopia: A Single-Arm Clinical Trial","volume":"66","author":"E Diro","year":"2018","journal-title":"Clin Infect Dis"},{"key":"ref28","unstructured":"AIDSinfo (2018) Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents. Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. T-15-T-25."},{"issue":"Suppl 1","key":"ref29","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1179\/000349803225002615","article-title":"The impact of highly active antiretroviral therapy (HAART) on visceral leishmaniasis in Spanish patients who are co-infected with HIV","volume":"97","author":"R Lopez-Velez","year":"2003","journal-title":"Ann Trop Med Parasitol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1179\/joc.2001.13.6.653","article-title":"Pentamidine isethionate as treatment and secondary prophylaxis for disseminated cutaneous leishmaniasis during HIV infection: case report","volume":"13","author":"L Calza","year":"2001","journal-title":"J Chemother"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1111\/j.1365-3156.2009.02329.x","article-title":"Pentamidine as secondary prophylaxis for visceral leishmaniasis in the immunocompromised host: report of four cases","volume":"14","author":"TA Patel","year":"2009","journal-title":"Trop Med Int Health"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0007132","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,3,5]],"date-time":"2019-03-05T00:00:00Z","timestamp":1551744000000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0007132","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T19:02:57Z","timestamp":1588964577000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0007132"}},"subtitle":[],"editor":[{"given":"Peter C.","family":"Melby","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,2,21]]},"references-count":31,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2019,2,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0007132","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pntd.0007132","asserted-by":"object"}]},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,21]]}}}